Cranial Nerve Neuromodulation for Stroke
(CN-NINM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help people regain arm strength after a stroke using cranial nerve non-invasive neuromodulation (CN-NINM). This technique stimulates nerves in the tongue to send signals to the brain, potentially boosting recovery and brain healing. Participants will receive either real or sham nerve stimulation along with arm strength training. The trial seeks individuals who had a stroke over six months ago, still have some arm movement, and are not currently in other rehabilitation programs. The goal is to determine if this treatment can eventually be used in homes and clinics to improve post-stroke recovery. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance recovery options for stroke survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
What prior data suggests that cranial nerve non-invasive neuromodulation is safe for stroke recovery?
A previous study used a technique called cranial nerve non-invasive neuromodulation (CN-NINM) alongside an arm strengthening program. This study suggested that the combination is feasible and may improve arm function in stroke survivors. Another study examined CN-NINM's effectiveness in enhancing movement and found it might also reduce pain.
Overall, CN-NINM is considered safe. As a non-invasive method, it does not involve surgery or entering the body, reducing the risk of serious side effects. So far, these studies have reported no major problems related to CN-NINM.
These findings suggest that CN-NINM could be a well-tolerated option for stroke recovery. However, more research is needed to fully understand its safety and effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about cranial nerve non-invasive neuromodulation (CN-NINM) for stroke recovery because it offers a novel approach to enhancing upper limb strength. Unlike traditional stroke rehabilitation methods, which often rely on physical therapy and medication to improve motor skills, CN-NINM stimulates cranial nerves directly without the need for surgery or drugs. This method leverages the body's natural pathways to potentially accelerate recovery and improve motor function more effectively. By combining this technique with strength training, the hope is to see faster and more significant improvements in stroke patients' ability to regain use of their upper limbs.
What evidence suggests that cranial nerve non-invasive neuromodulation is effective for stroke recovery?
Research shows that cranial nerve non-invasive neuromodulation (CN-NINM) might improve arm function in people recovering from a stroke. In this trial, participants will be divided into two groups: one will receive real CN-NINM combined with upper limb strength training, while the other will receive sham CN-NINM with the same training. Previous studies have shown that stroke survivors using CN-NINM with arm exercises experienced better arm movement. Another study found that CN-NINM might also aid walking and balance. This treatment works by gently stimulating nerves in the tongue, leading to brain changes that aid recovery. While results are promising for various brain-related conditions, researchers are still determining its effectiveness specifically for arm recovery after a stroke.12678
Who Is on the Research Team?
Marie-Helene Milot, PhD
Principal Investigator
Université de Sherbrooke
Are You a Good Fit for This Trial?
This trial is for individuals in the chronic phase of stroke recovery who still have muscle weakness in their arm. They will participate in a 4-week program to improve arm function, which includes strength training and either real or sham cranial nerve stimulation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 4-week individualized upper limb strength training program combined with real or sham cranial nerve non-invasive neuromodulation (CN-NINM)
Follow-up
Participants are monitored for changes in motor cortex excitability and upper limb function after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Cranial nerve non-invasive neuromodulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université de Sherbrooke
Lead Sponsor
Heart and Stroke Foundation of Canada
Collaborator